Weiser Michael
SEC-identified person · CIK 1221449 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Lion Biotechnologies, Inc. N/A | Director | filed 2018–2026 |
| Ziopharm Oncology INC ZIOP | Director | filed 2006–2018 |
| Emisphere Technologies INC EMIS | Director | filed 2006–2017 |
| Chelsea Therapeutics International, Ltd. CHTP.OB | Director | filed 2006–2014 |
| TG Therapeutics, INC. TGTXD | Director | filed 2006–2010 |
| Talon Therapeutics, Inc. TLON.OB | Director | filed 2006–2010 |
| Vioquest Pharmaceuticals, Inc. VQPH | Director | filed 2007–2008 |
| Kodiak Sciences, INC. | Director · President and Secretary | filed 2006–2008 |
| Kanai Sciences, INC. | Director · President and Secretary | filed 2006–2008 |
| Seward Sciences, INC. | Director · President and Secretary | filed 2006–2008 |
| Innovive Pharmaceuticals, Inc. NA | Director | filed 2006–2006 |
| Paramount Acquisition Corp [PMQC. OB] | Director · Executive Vice President | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.